Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Sex chromosome composition of complete hydatidiform moles: relationship to metastasis

Article Abstract:

Patients with a hydatidiform mole that is Y chromosome-positive may not have a higher risk of metastatic disease than those with a hydatidiform mole that is Y chromosome-negative. A hydatidiform mole is an abnormal pregnancy that results in a mass of cysts resembling a bunch of grapes. Among 35 patients with hydatidiform moles that were analysed using polymerase chain reaction (PCR), 13 developed metastatic disease and 22 did not. A Y chromosome was found in 8% of the hydatidiform moles from patients with metastatic disease, compared to 9% of those without metastatic disease. The Y chromosome is the male sex chromosome.

Author: Genest, David R., Mutter, George L., Pomponio, Robert J., Berkowitz, Ross S.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1993
Complications and side effects, Sex chromosome abnormalities

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Genetic differentiation of complete hydatidiform moles coexisting with normal fetuses by short tandem repeat-derived deoxyribonucleic acid polymorphism analysis

Article Abstract:

A type of genetic analysis called short tandem repeat-derived deoxyribonucleic acid polymorphism analysis can be used to determine whether a complete hydatidiform molar pregnancy contains a viable fetus. A molar pregnancy occurs when a sperm fertilizes an egg with no nucleus or two sperm fertilize a normal egg. Researchers used this technique on six pregnant women with twin pregnancies, one of which appeared to be a normal fetus and the other a molar pregnancy. The technique revealed normal parental chromosomes in the normal fetus but only paternal chromosomes in the molar pregnancy.

Author: Osada, Hisao, Ishii, Jo, Iitsuka, Yoshinori, Takano, Hajime, Matsui, Hideo, Sekiya, Souei
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
Genetic polymorphisms

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles

Article Abstract:

A study was conducted to determine the optimal duration of human chrionic gonadotropin surveillance. The results support the suggestion that a single undetecundetectable human chorionic gonadotropin level after evacuation is sufficient follow-up to ensure remission in patients with partial hydatidiform moles.

Author: Miller, David S., Schorge, John O., Lavie, Isaac, Rao, Gautam G., Castrillion, Diego H.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2005
United States, Science & research, Health aspects, Research, Chorionic gonadotropin, Chorionic gonadotropins, Pregnancy, Molar, Trophoblastic tumours

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Risk factors, Genetic aspects, Molar pregnancy, Trophoblastic tumors, Hydatidiform mole
Similar abstracts:
  • Abstracts: A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis
  • Abstracts: Managed competition backed despite questions. The bottom line. Friend or foe? Rural doctors unsure
  • Abstracts: Clinical characteristics and outcome of twin gestation complicated by preterm premature rupture of the membranes
  • Abstracts: Hormone replacement therapy and risk of breast cancer: results of epidemiologic studies. Post-menopausal hormone use and tooth loss: a prospective study
  • Abstracts: Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.